What are analysts Suggestions on Rio Tinto Plc(NYSE:RIO): SELLAS Life Sciences Group, Inc. (NASDAQ:SLS)

0
4

Many analysts are providing their Estimated Earnings analysis for Rio Tinto Plc and for the current quarter 0 analysts have projected that the stock could give an Average Earnings estimate of $0/share. These analysts have also projected a Low Estimate of $0/share and a High Estimate of $0/share.

Some buy side analysts are also providing their Analysis on Rio Tinto Plc, where 3 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 1 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

Rio Tinto Plc closed its last trading session at $62.06 with the gain of 1.16%. The Market Capitalization of the company stands at 105.52 Billion. The Company has 52-week high of $62.95 and 52-week low of $42.79. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 6.31% where SMA50 and SMA200 are 10.74% and 24.98% respectively. The Company Touched its 52-Week High on 04/12/19 and 52-Week Low on 12/10/18.

The Relative Volume of the company is 0.56 and Average Volume (3 months) is 3.18 million. The company’s P/E (price to earnings) ratio is 7.94 and Forward P/E ratio of 11.19.

The company shows its Return on Assets (ROA) value of 14.9%. The Return on Equity (ROE) value stands at 31.5%. While it’s Return on Investment (ROI) value is 23.7%.

While looking at the Stock’s Performance, Rio Tinto Plc currently shows a Weekly Performance of 2.8%, where Monthly Performance is 12.11%, Quarterly performance is 29.61%, 6 Months performance is 34.35% and yearly performance percentage is 21.66%. Year to Date performance value (YTD perf) value is 35.04%. The Stock currently has a Weekly Volatility of 1.04% and Monthly Volatility of 1.26%.

SELLAS Life Sciences Group, Inc. (SLS) will report its next earnings on Apr 04 BMO. The company reported the earnings of $-0.17/Share in the last quarter where the estimated EPS by analysts was $-0.23/share. The difference between the expected and actual EPS was $0.06/share, which represents an Earnings surprise of 26.1%.

Many analysts are providing their Estimated Earnings analysis for SELLAS Life Sciences Group, Inc. and for the current quarter 2 analysts have projected that the stock could give an Average Earnings estimate of $-0.2/share. These analysts have also projected a Low Estimate of $-0.23/share and a High Estimate of $-0.18/share.

These analysts also forecasted Growth Estimates for the Current Quarter for SLS to be 81.6%. They are projecting Next Quarter growth of 85.71%. For the next 5 years, SELLAS Life Sciences Group, Inc. is expecting Growth of -16.87% per annum, whereas in the past 5 years the growth was 74.77% per annum.

Some buy side analysts are also providing their Analysis on SELLAS Life Sciences Group, Inc. , where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 1 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for SELLAS Life Sciences Group, Inc. might touch $13 high while the Average Price Target and Low price Target is $8.75 and $4.5 respectively.

SELLAS Life Sciences Group, Inc. closed its last trading session at $1.07 with the loss of -2.8%. The Market Capitalization of the company stands at 24.13 Million. The Company has 52-week high of $6.97 and 52-week low of $0.80. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -6.45% where SMA50 and SMA200 are -19.42% and -29.01% respectively. The Company Touched its 52-Week High on 06/01/18 and 52-Week Low on 08/20/18.

The Relative Volume of the company is 0.75 and Average Volume (3 months) is 323.47 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -136.5%. The Return on Equity (ROE) value stands at -829.1%. While it’s Return on Investment (ROI) value is 0%.

While looking at the Stock’s Performance, SELLAS Life Sciences Group, Inc. currently shows a Weekly Performance of 0.97%, where Monthly Performance is -24.64%, Quarterly performance is -36.2%, 6 Months performance is -18.75% and yearly performance percentage is -83.03%. Year to Date performance value (YTD perf) value is -15.45%. The Stock currently has a Weekly Volatility of 7.37% and Monthly Volatility of 7.56%.

SHARE